These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors. Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755 [TBL] [Abstract][Full Text] [Related]
4. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
5. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I; Cepulić BG; Mazić S Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [TBL] [Abstract][Full Text] [Related]
6. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model. Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478 [TBL] [Abstract][Full Text] [Related]
7. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection. Zhang C; Zhang X; Chen XH Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971 [TBL] [Abstract][Full Text] [Related]
8. The role of accessory cells in allogeneic peripheral blood stem cell transplantation. Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453 [TBL] [Abstract][Full Text] [Related]
9. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212 [TBL] [Abstract][Full Text] [Related]
10. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation. MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491 [TBL] [Abstract][Full Text] [Related]
11. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Zhao XY; Xu LL; Lu SY; Huang XJ Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte-mobilized bone marrow. Arcese W; De Angelis G; Cerretti R Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729 [TBL] [Abstract][Full Text] [Related]
13. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051 [TBL] [Abstract][Full Text] [Related]
14. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells. Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205 [TBL] [Abstract][Full Text] [Related]
15. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease. Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062 [TBL] [Abstract][Full Text] [Related]
16. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543 [TBL] [Abstract][Full Text] [Related]
17. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation. Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397 [TBL] [Abstract][Full Text] [Related]